32 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
34414360	60	Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir.	The University of Arizona
9832156	13	Characterization of (2S,2'R,3'R)-2-(2',3'-[3H]-dicarboxycyclopropyl)glycine binding in rat brain.	F. Hoffmann-La Roche
14613121	8	Rapid diversity-oriented synthesis in microtiter plates for in situ screening of HIV protease inhibitors.	The Scripps Research Institute
21802008	10	High-throughput kinase profiling: a more efficient approach toward the discovery of new kinase inhibitors.	Harvard Medical School
19167883	5	Tricyclic HIV integrase inhibitors: VI. SAR studies of 'benzyl flipped' C3-substituted pyrroloquinolines.	Gilead Sciences
17949010	16	Novel mechanistic class of fatty acid amide hydrolase inhibitors with remarkable selectivity.	Pfizer
18378449	12	Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.	Astrazeneca
12670229	8	Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.	Abbott Laboratories
16451067	16	Potent CYP19 (aromatase) 1-[(benzofuran-2-yl)(phenylmethyl)pyridine, -imidazole, and -triazole inhibitors: synthesis and biological evaluation.	Cardiff University
11378361	25	4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.	Dupont Pharmaceuticals
9371233	24	Synthesis of 5,6-dihydro-4-hydroxy-2-pyrones as HIV-1 protease inhibitors: the profound effect of polarity on antiviral activity.	Parke-Davis Pharmaceutical Research
8558507	7	A novel, picomolar inhibitor of human immunodeficiency virus type 1 protease.	Abbott Laboratories